McMinn Rachel

McMinn Rachel is listed in filings as Chief Executive Officer at Neurogene Inc.. This profile follows SEC Form 4 activity through Mar 30, 2026, including purchase activity and sale activity. Recent filings connect the profile to Neurogene Inc. (NGNE). The current snapshot covers public activity from Nov 25, 2024 to Mar 30, 2026. Reported amounts are shown as $969.0K to $2.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.